 | • レポートコード：QY20ST-07005 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の市販（OTC）薬市場について種類別（鎮痛剤、皮膚科製品、消化器製品、ビタミン、ミネラル、サプリメント（VMS）、減量/栄養製品、眼科製品、睡眠補助剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・市販（OTC）薬市場の概要 ・世界の主要地域別市販（OTC）薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の市販（OTC）薬市場規模2015-2026：種類別（鎮痛剤、皮膚科製品、消化器製品、ビタミン、ミネラル、サプリメント（VMS）、減量/栄養製品、眼科製品、睡眠補助剤、その他） ・世界の市販（OTC）薬市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局、その他） ・市販（OTC）薬の北米市場規模2015-2020 ・市販（OTC）薬のヨーロッパ市場規模2015-2020 ・市販（OTC）薬の中国市場規模2015-2020 ・市販（OTC）薬の日本市場規模2015-2020 ・市販（OTC）薬の東南アジア市場規模2015-2020 ・市販（OTC）薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・市販（OTC）薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・市販（OTC）薬の市場動向・機会・課題 ・調査の結論 |
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Market Analysis and Insights: Global Over The Counter (OTC) Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Over The Counter (OTC) Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Over The Counter (OTC) Drugs industry.
Based on our recent survey, we have several different scenarios about the Over The Counter (OTC) Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Over The Counter (OTC) Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Over The Counter (OTC) Drugs Scope and Market Size
The global Over The Counter (OTC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over The Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Over The Counter (OTC) Drugs market is segmented into
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight Loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others
Segment by Application, the Over The Counter (OTC) Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
The Over The Counter (OTC) Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Over The Counter (OTC) Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over The Counter (OTC) Drugs Market Share Analysis
Over The Counter (OTC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over The Counter (OTC) Drugs business, the date to enter into the Over The Counter (OTC) Drugs market, Over The Counter (OTC) Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer AG
Boehringer Ingelheim
GlaxoSmithKline PLC
Johnson & Johnson
Novartis International AG
Pfizer,Inc.
PGT healthcare
Sanofi S.A
Takeda
1 Over The Counter (OTC) Drugs Market Overview
1.1 Over The Counter (OTC) Drugs Product Scope
1.2 Over The Counter (OTC) Drugs Segment by Type
1.2.1 Global Over The Counter (OTC) Drugs Sales by Type (2020-2026)
1.2.2 Analgesics
1.2.3 Dermatology Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamins, Mineral, and Supplements (VMS)
1.2.6 Weight Loss/Dietary Products
1.2.7 Ophthalmic Products
1.2.8 Sleeping Aids
1.2.9 Others
1.3 Over The Counter (OTC) Drugs Segment by Application
1.3.1 Global Over The Counter (OTC) Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Over The Counter (OTC) Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Over The Counter (OTC) Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Over The Counter (OTC) Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Over The Counter (OTC) Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Over The Counter (OTC) Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Over The Counter (OTC) Drugs Industry
1.5.1.1 Over The Counter (OTC) Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Over The Counter (OTC) Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Over The Counter (OTC) Drugs Players to Combat Covid-19 Impact
2 Over The Counter (OTC) Drugs Estimate and Forecast by Region
2.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Over The Counter (OTC) Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Over The Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Over The Counter (OTC) Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Over The Counter (OTC) Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Over The Counter (OTC) Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Over The Counter (OTC) Drugs Estimates and Projections (2015-2026)
2.4.3 China Over The Counter (OTC) Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Over The Counter (OTC) Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Over The Counter (OTC) Drugs Estimates and Projections (2015-2026)
2.4.6 India Over The Counter (OTC) Drugs Estimates and Projections (2015-2026)
3 Global Over The Counter (OTC) Drugs Competition Landscape by Players
3.1 Global Top Over The Counter (OTC) Drugs Players by Sales (2015-2020)
3.2 Global Top Over The Counter (OTC) Drugs Players by Revenue (2015-2020)
3.3 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over The Counter (OTC) Drugs as of 2019)
3.4 Global Over The Counter (OTC) Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Over The Counter (OTC) Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Over The Counter (OTC) Drugs Players (Opinion Leaders)
4 Global Over The Counter (OTC) Drugs Market Size by Type
4.1 Global Over The Counter (OTC) Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Over The Counter (OTC) Drugs Price by Type (2014-2020)
4.2 Global Over The Counter (OTC) Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Over The Counter (OTC) Drugs Price Forecast by Type (2021-2026)
5 Global Over The Counter (OTC) Drugs Market Size by Application
5.1 Global Over The Counter (OTC) Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Over The Counter (OTC) Drugs Price by Application (2015-2020)
5.2 Global Over The Counter (OTC) Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Over The Counter (OTC) Drugs Price Forecast by Application (2021-2026)
3 North America Over The Counter (OTC) Drugs Market Facts & Figures
3.2 North America Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
3.3 North America Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
3.4 North America Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
4 Europe Over The Counter (OTC) Drugs Market Facts & Figures
4.2 Europe Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
5 China Over The Counter (OTC) Drugs Market Facts & Figures
5.2 China Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
5.3 China Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
5.4 China Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
6 Japan Over The Counter (OTC) Drugs Market Facts & Figures
6.2 Japan Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Over The Counter (OTC) Drugs Market Facts & Figures
7.2 Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
8 India Over The Counter (OTC) Drugs Market Facts & Figures
8.2 India Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
8.3 India Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
8.4 India Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Over The Counter (OTC) Drugs Business
12.1 Bayer AG
12.1.1 Bayer AG Over The Counter (OTC) Drugs Corporation Information
12.1.2 Bayer AG Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.1.3 Bayer AG Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
12.1.5 Bayer AG Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Over The Counter (OTC) Drugs Corporation Information
12.2.2 Boehringer Ingelheim Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.2.3 Boehringer Ingelheim Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boehringer Ingelheim Over The Counter (OTC) Drugs Products Offered
12.2.5 Boehringer Ingelheim Recent Development
12.3 GlaxoSmithKline PLC
12.3.1 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Corporation Information
12.3.2 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.3.3 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Products Offered
12.3.5 GlaxoSmithKline PLC Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Over The Counter (OTC) Drugs Corporation Information
12.4.2 Johnson & Johnson Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Novartis International AG
12.5.1 Novartis International AG Over The Counter (OTC) Drugs Corporation Information
12.5.2 Novartis International AG Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.5.3 Novartis International AG Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis International AG Over The Counter (OTC) Drugs Products Offered
12.5.5 Novartis International AG Recent Development
12.6 Pfizer,Inc.
12.6.1 Pfizer,Inc. Over The Counter (OTC) Drugs Corporation Information
12.6.2 Pfizer,Inc. Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.6.3 Pfizer,Inc. Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer,Inc. Over The Counter (OTC) Drugs Products Offered
12.6.5 Pfizer,Inc. Recent Development
12.7 PGT healthcare
12.7.1 PGT healthcare Over The Counter (OTC) Drugs Corporation Information
12.7.2 PGT healthcare Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.7.3 PGT healthcare Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 PGT healthcare Over The Counter (OTC) Drugs Products Offered
12.7.5 PGT healthcare Recent Development
12.8 Sanofi S.A
12.8.1 Sanofi S.A Over The Counter (OTC) Drugs Corporation Information
12.8.2 Sanofi S.A Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.8.3 Sanofi S.A Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi S.A Over The Counter (OTC) Drugs Products Offered
12.8.5 Sanofi S.A Recent Development
12.9 Takeda
12.9.1 Takeda Over The Counter (OTC) Drugs Corporation Information
12.9.2 Takeda Over The Counter (OTC) Drugs Business Overview and Total Revenue
12.9.3 Takeda Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Takeda Over The Counter (OTC) Drugs Products Offered
12.9.5 Takeda Recent Development
13 Over The Counter (OTC) Drugs Manufacturing Cost Analysis
13.1 Over The Counter (OTC) Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Over The Counter (OTC) Drugs
13.4 Over The Counter (OTC) Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Over The Counter (OTC) Drugs Distributors List
14.3 Over The Counter (OTC) Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Over The Counter (OTC) Drugs Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Over The Counter (OTC) Drugs Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Over The Counter (OTC) Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Over The Counter (OTC) Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Over The Counter (OTC) Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Over The Counter (OTC) Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Over The Counter (OTC) Drugs Sales (K MT) by Region (2015-2020)
Table 10. Global Over The Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Over The Counter (OTC) Drugs Revenue Share by Region (2015-2020)
Table 13. Global Over The Counter (OTC) Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Over The Counter (OTC) Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Over The Counter (OTC) Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Over The Counter (OTC) Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Over The Counter (OTC) Drugs (K MT) of Key Companies (2015-2020)
Table 18. Global Over The Counter (OTC) Drugs Sales Share by Company (2015-2020)
Table 19. Global Over The Counter (OTC) Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Over The Counter (OTC) Drugs Revenue Share by Company (2015-2020)
Table 21. Global Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over The Counter (OTC) Drugs as of 2019)
Table 22. Global Over The Counter (OTC) Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Over The Counter (OTC) Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Over The Counter (OTC) Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Over The Counter (OTC) Drugs Players
Table 27. Global Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 28. Global Over The Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 29. Global Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Over The Counter (OTC) Drugs Price (K MT) by Type (2015-2020)
Table 31. Global Over The Counter (OTC) Drugs Sales Share by Type (2021-2026)
Table 32. Global Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Over The Counter (OTC) Drugs Revenue Share by Type (2021-2026)
Table 34. Global Over The Counter (OTC) Drugs Price (K MT) by Type (2021-2026)
Table 35. Global Over The Counter (OTC) Drugs Sales (K MT) by Application (2015-2020)
Table 36. Global Over The Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 37. Global Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Over The Counter (OTC) Drugs Price (K MT) by Application (2015-2020)
Table 39. Global Over The Counter (OTC) Drugs Sales (K MT) by Application (2021-2026)
Table 40. Global Over The Counter (OTC) Drugs Sales Share by Application (2021-2026)
Table 41. Global Over The Counter (OTC) Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Over The Counter (OTC) Drugs Revenue Share by Application (2021-2026)
Table 43. Global Over The Counter (OTC) Drugs Price (K MT) by Application (2021-2026)
Table 44. United States Over The Counter (OTC) Drugs Sales (K MT) by Company (2015-2020)
Table 45. United States Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 47. United States Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Over The Counter (OTC) Drugs Sales (K MT) by Application (2015-2020)
Table 49. United States Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Over The Counter (OTC) Drugs Sales (K MT) by Company (2015-2020)
Table 51. Europe Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 53. Europe Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Over The Counter (OTC) Drugs Sales (K MT) by Application (2015-2020)
Table 55. Europe Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 56. China Over The Counter (OTC) Drugs Sales (K MT) by Company (2015-2020)
Table 57. China Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
Table 58. China Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 59. China Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 60. China Over The Counter (OTC) Drugs Sales (K MT) by Application (2015-2020)
Table 61. China Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Over The Counter (OTC) Drugs Sales (K MT) by Company (2015-2020)
Table 63. Japan Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 65. Japan Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Over The Counter (OTC) Drugs Sales (K MT) by Application (2015-2020)
Table 67. Japan Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Over The Counter (OTC) Drugs Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 74. India Over The Counter (OTC) Drugs Sales (K MT) by Company (2015-2020)
Table 75. India Over The Counter (OTC) Drugs Sales Market Share by Company (2015-2020)
Table 76. India Over The Counter (OTC) Drugs Sales (K MT) by Type (2015-2020)
Table 77. India Over The Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Table 78. India Over The Counter (OTC) Drugs Sales (K MT) by Application (2015-2020)
Table 79. India Over The Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Table 80. Bayer AG Corporation Information
Table 81. Bayer AG Description and Business Overview
Table 82. Bayer AG Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bayer AG Over The Counter (OTC) Drugs Product
Table 84. Bayer AG Recent Development
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Boehringer Ingelheim Over The Counter (OTC) Drugs Product
Table 89. Boehringer Ingelheim Recent Development
Table 90. GlaxoSmithKline PLC Corporation Information
Table 91. GlaxoSmithKline PLC Description and Business Overview
Table 92. GlaxoSmithKline PLC Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline PLC Over The Counter (OTC) Drugs Product
Table 94. GlaxoSmithKline PLC Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Over The Counter (OTC) Drugs Product
Table 99. Johnson & Johnson Recent Development
Table 100. Novartis International AG Corporation Information
Table 101. Novartis International AG Description and Business Overview
Table 102. Novartis International AG Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Novartis International AG Over The Counter (OTC) Drugs Product
Table 104. Novartis International AG Recent Development
Table 105. Pfizer,Inc. Corporation Information
Table 106. Pfizer,Inc. Description and Business Overview
Table 107. Pfizer,Inc. Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Pfizer,Inc. Over The Counter (OTC) Drugs Product
Table 109. Pfizer,Inc. Recent Development
Table 110. PGT healthcare Corporation Information
Table 111. PGT healthcare Description and Business Overview
Table 112. PGT healthcare Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. PGT healthcare Over The Counter (OTC) Drugs Product
Table 114. PGT healthcare Recent Development
Table 115. Sanofi S.A Corporation Information
Table 116. Sanofi S.A Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Sanofi S.A Description and Business Overview
Table 118. Sanofi S.A Over The Counter (OTC) Drugs Product
Table 119. Sanofi S.A Recent Development
Table . Takeda Corporation Information
Table . Takeda Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Takeda Description and Business Overview
Table . Takeda Over The Counter (OTC) Drugs Product
Table . Takeda Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Over The Counter (OTC) Drugs Distributors List
Table 128. Over The Counter (OTC) Drugs Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Over The Counter (OTC) Drugs Product Picture
Figure 2. Global Over The Counter (OTC) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Over The Counter (OTC) Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacy Examples
Figure 9. Others Examples
Figure 10. Global Over The Counter (OTC) Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Over The Counter (OTC) Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Over The Counter (OTC) Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Over The Counter (OTC) Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Over The Counter (OTC) Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Over The Counter (OTC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Over The Counter (OTC) Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Over The Counter (OTC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Over The Counter (OTC) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Over The Counter (OTC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Over The Counter (OTC) Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Over The Counter (OTC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Over The Counter (OTC) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Over The Counter (OTC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Over The Counter (OTC) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Over The Counter (OTC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Over The Counter (OTC) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Over The Counter (OTC) Drugs Players Market Share by Revenue in Over The Counter (OTC) Drugs 2015 & 2019
Figure 28. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Over The Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Figure 30. Global Over The Counter (OTC) Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Over The Counter (OTC) Drugs Revenue Share by Application (2015-2020)
Figure 32. Global Over The Counter (OTC) Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 34. United States Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 35. Europe Over The Counter (OTC) Drugs Sales Market Share by Company in 2019
Figure 36. Europe Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 37. Europe Over The Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 38. China Over The Counter (OTC) Drugs Sales Market Share by Company in 2019
Figure 39. China Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 40. China Over The Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 41. Japan Over The Counter (OTC) Drugs Sales Market Share by Company in 2019
Figure 42. Japan Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 43. Japan Over The Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 44. Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Company in 2019
Figure 45. Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 46. Southeast Asia Over The Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 47. India Over The Counter (OTC) Drugs Sales Market Share by Company in 2019
Figure 48. India Over The Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 49. India Over The Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 50. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GlaxoSmithKline PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Pfizer,Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. PGT healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sanofi S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Over The Counter (OTC) Drugs
Figure 61. Manufacturing Process Analysis of Over The Counter (OTC) Drugs
Figure 62. Over The Counter (OTC) Drugs Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
店頭販売（OTC）薬・栄養補助食品の世界市場レポート2020 Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They …- 体細胞カウンターの世界市場レポート2020 A recently published report by QY Research titled Global Somatic Cell Counter Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accura…
- 減量薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Weight Loss Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Weight Loss Drugs market re…
- カウンタードローンシステムの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Counter Drone System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Counter Drone System mar…
- 軍用装甲車両・カウンターIED車両の世界市場レポート2020 Military armored vehicles and counter IED vehicles are armored and armed vehicles widely used in warfare and border patrol.They provide military personnel with protection from bombs and improvised explosive devices, Market Analysis and Insights: Global Military Armored Vehicles and Counter IED Vehic…